The markets closed mixed with the Dow adding 15 points to 12,965 over concerns that the Greek economy will remain in a prolonged recession. Nasdaq slipped 3 points to 2948.
On the upside
Shareholders approved the merger of Eldorado Gold (NYSE: EGO) with European Goldfields.
Shares of Polypore International (NYSE: PPO) advanced ahead of its earnings release tomorrow.
On the downside
The Food and Drug Administration suspended drug trials of GTx's (Nasdaq: GTXI) prostate cancer treatment Capesaris due to an increased risk of bloom clots.
FDATracker.com expects the Food and Drug Administration to reject Vivus' (Nasdaq: VVUS) obesity treatment Qnexa.
Boyd Gaming (NYSE: BYD) narrowed fourth quarter losses but the results fell short of analyst expectations.
In the broad market, declining issues outpaced advancers by a slim margin on the NYSE and by more than 5 to 3 on Nasdaq. The Russell 2000 which tracks small cap stocks lost 5 points to 823.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here